摘要
本文介绍了合理药物设计的各种技术。该方法的基础是用新的原子和(或)原子群替代训练数据集分子中的反药效团原子,从而增加合成孔径雷达(SAR)研究得到的原子生物活性增量。在此基础上,提出了一种基于遗传算法的新药候选结构离散优化和生成的设计方法。此外,还描述了利用Mera力场和/或AlteQ量子化学方法对生物活性和生物活性概率进行正确预测的SAR方法(基于3D/4D QSAR内部和外部的方法-BIS、Cis、刚果、COMIN、高质量对接方法-R坞)的宽光谱。这些设计方法是在www.chemosophia.com网站上实现的,用于在线计算服务。
关键词: 药物设计,对接,3D/4D QSAR,遗传算法,虚拟筛选,抗药效团。
Current Medicinal Chemistry
Title:Grid-Based Technologies for In Silico Screening and Drug Design
Volume: 25 Issue: 29
关键词: 药物设计,对接,3D/4D QSAR,遗传算法,虚拟筛选,抗药效团。
摘要: Various techniques for rational drug design are presented in the paper. The methods are based on a substitution of antipharmacophore atoms of the molecules of training dataset by new atoms and/or group of atoms increasing the atomic bioactivity increments obtained from an SAR study. Furthermore, a design methodology based on the genetic algorithm DesPot for discrete optimization and generation of new drug candidate structures is described. Additionally, wide spectra of SAR approaches (3D/4D QSAR interior and exterior-based methods – BiS, CiS, ConGO, CoMIn, high-quality docking method - ReDock) using MERA force field and/or AlteQ quantum chemical method for correct prognosis of bioactivity and the bioactive probability have been described. The design methods are implemented at www.chemosophia.com web-site for online computational services.
Export Options
About this article
Cite this article as:
Grid-Based Technologies for In Silico Screening and Drug Design, Current Medicinal Chemistry 2018; 25 (29) . https://dx.doi.org/10.2174/0929867325666180309112454
DOI https://dx.doi.org/10.2174/0929867325666180309112454 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements